Literature DB >> 31972051

Identification of cases and estimate of direct costs of unresectable and advanced cutaneous squamous cell carcinoma: real-world data from a large Italian database.

G Ronconi1, C Piccinni1, L Dondi1, S Calabria1, A Pedrini1, I Esposito2, P A Ascierto3, L Naldi4,5, N Martini1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31972051     DOI： 10.1111/bjd.18888

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  2 in total

1.  Preliminary Cost-Effectiveness and Cost-Utility Analysis of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma in Italy.

Authors:  Gianni Ghetti; Maria Claudia D'Avella; Lorenzo Pradelli
Journal:  Clinicoecon Outcomes Res       Date:  2021-02-10

2.  Clinicopathological characteristics and clinical morbidity in high-risk head and neck cutaneous squamous cell carcinoma patients in Western Australia.

Authors:  Piyush Grover; Stephanie Flukes; Angela Jacques; Samuel Leedman; Andrew Lindsay; Rohen White; Peter Friedland; Reuven Gurfinkel; Annette M Lim
Journal:  Intern Med J       Date:  2022-04-06       Impact factor: 2.611
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.